Alopexx Expands Leadership Team with Appointment of Thomas T. Thomas as Chief Financial Officer

/PRNewswire/ -- Alopexx, Inc. a clinical stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Thomast Thomas ,Daniel Vlock ,Governance Committee ,Stupski Foundation ,Prnewswire Alopexx Inc ,Genentech ,Genentech Inc ,Compensation Committee ,Board Of Opiant Pharmaceuticals ,University Of Cincinnati College ,Nasdaq ,Audit Committee ,Alopexx Inc ,University Of Cincinnati College Business ,Corporate Investment Program ,Business Development ,Genentech South Campus Research Center Expansion ,Interim Chief Executive Officer ,Corporate Treasurer ,Enterprise Risk Management ,Drug Collaborations ,Global Public Debt Offering ,South Campus Research Center Expansion ,Independent Director ,Opiant Pharmaceuticals ,Chartered Financial Analyst ,Cincinnati College ,Cincinnati College Conservatory ,